<http://www.reactome.org/biopax/48892Evidence5532> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.biopax.org/release/biopax-level3.owl#Evidence> .
<http://www.reactome.org/biopax/48892Evidence5532> <http://www.biopax.org/release/biopax-level3.owl#comment> "L1 cross linking can activate MAPK cascade components MEK1/2, ERK1/2, as well as Src, Raf-1,and p90rsk. MAP kinase signaling requires endocytosis mediated by Src. ERK2 can phos-phorylate internalized L1 at serine residues 1204 and 1248. This phosphorylation may increase the neurite growth."^^<http://www.w3.org/2001/XMLSchema#string> .
<http://www.reactome.org/biopax/48892Evidence5532> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/10818153> .
<http://www.reactome.org/biopax/48892Evidence5532> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/10608864> .
<http://www.reactome.org/biopax/48892Evidence5532> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/17151951> .
<http://www.reactome.org/biopax/48892Evidence5532> <http://www.biopax.org/release/biopax-level3.owl#evidenceCode> <http://www.reactome.org/biopax/48892EvidenceCodeVocabulary1> .